Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

M Hassanein; W Hanif; Waqar Malik; Ali Kamal; P Geransar; N Lister; C Andrews; Anthony Barnett

doi:10.1185/03007995.2011.579951

Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

M Hassanein
, W Hanif
, Waqar Malik
, Ali Kamal
, P Geransar
, N Lister
, C Andrews
, Anthony Barnett

Research output: Contribution to journal › Article

57 Citations (Scopus)

Abstract

Objective: To compare the incidence of hypoglycaemic events (HEs) in a real-world setting in Muslim patients with type 2 diabetes mellitus fasting during Ramadan. Research design and methods: We performed a

Original language	English
Pages (from-to)	1367-1374
Number of pages	8
Journal	Current Medical Research and Opinion
Volume	27
Issue number	7
DOIs	https://doi.org/10.1185/03007995.2011.579951
Publication status	Published - 1 Jul 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Diabetes mellitus, type 2
Dipeptidyl-peptidase 4 inhibitors
Fasting hypoglycaemia
Vildagliptin
Muslims

Access to Document

10.1185/03007995.2011.579951

Fingerprint

Dive into the research topics of 'Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study'. Together they form a unique fingerprint.

Cite this

Hassanein, M., Hanif, W., Malik, W., Kamal, A., Geransar, P., Lister, N., Andrews, C., & Barnett, A. (2011). Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study. Current Medical Research and Opinion, 27(7), 1367-1374. https://doi.org/10.1185/03007995.2011.579951

@article{1ea68f615a5f4046983aca41a423e7f8,

title = "Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study",

abstract = "Objective: To compare the incidence of hypoglycaemic events (HEs) in a real-world setting in Muslim patients with type 2 diabetes mellitus fasting during Ramadan. Research design and methods: We performed a ",

keywords = "Diabetes mellitus, type 2, Dipeptidyl-peptidase 4 inhibitors, Fasting hypoglycaemia, Vildagliptin, Muslims",

author = "M Hassanein and W Hanif and Waqar Malik and Ali Kamal and P Geransar and N Lister and C Andrews and Anthony Barnett",

year = "2011",

month = jul,

day = "1",

doi = "10.1185/03007995.2011.579951",

language = "English",

volume = "27",

pages = "1367--1374",

journal = "Current Medical Research and Opinion",

issn = "1473-4877",

publisher = "Taylor \& Francis",

number = "7",

}

Hassanein, M, Hanif, W, Malik, W, Kamal, A, Geransar, P, Lister, N, Andrews, C & Barnett, A 2011, 'Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study', Current Medical Research and Opinion, vol. 27, no. 7, pp. 1367-1374. https://doi.org/10.1185/03007995.2011.579951

Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study. / Hassanein, M; Hanif, W; Malik, Waqar et al.
In: Current Medical Research and Opinion, Vol. 27, No. 7, 01.07.2011, p. 1367-1374.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

AU - Hassanein, M

AU - Hanif, W

AU - Malik, Waqar

AU - Kamal, Ali

AU - Geransar, P

AU - Lister, N

AU - Andrews, C

AU - Barnett, Anthony

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Objective: To compare the incidence of hypoglycaemic events (HEs) in a real-world setting in Muslim patients with type 2 diabetes mellitus fasting during Ramadan. Research design and methods: We performed a

AB - Objective: To compare the incidence of hypoglycaemic events (HEs) in a real-world setting in Muslim patients with type 2 diabetes mellitus fasting during Ramadan. Research design and methods: We performed a

KW - Diabetes mellitus, type 2

KW - Dipeptidyl-peptidase 4 inhibitors

KW - Fasting hypoglycaemia

KW - Vildagliptin

KW - Muslims

U2 - 10.1185/03007995.2011.579951

DO - 10.1185/03007995.2011.579951

M3 - Article

C2 - 21568833

SN - 1473-4877

VL - 27

SP - 1367

EP - 1374

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

IS - 7

ER -

Hassanein M, Hanif W, Malik W, Kamal A, Geransar P, Lister N et al. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study. Current Medical Research and Opinion. 2011 Jul 1;27(7):1367-1374. doi: 10.1185/03007995.2011.579951